Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
Clinical trial NCT05153135 · COMPLETED
Trial details
- NCT number
- NCT05153135
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-08
- Primary completion
- 2020-07-31
- Enrollment
- 4320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.